Article information Background: One of the most common procedures for changing the shape of a person's body is abdominoplasty, which often includes monsplasty. It is one of the top five procedures in cosmetic surgery. Abdominoplasty and body lift operations may begin with a monsplasty. Here, we detail a novel method for treating pubic deformities triggered by massive weight reduction. Aim of the Work: The purpose of this research was to evaluate how happy our patients were with the results of their monsplasty and abdominoplasty procedures following significant weight loss. Our team also tried to develop a surgical care decision-making system. Patients and Methods: This prospective study involved 30 cases designed to assess the outcome of a combination of both abdominoplasty with monsplasty in patients with massive weight loss either dietary or post bariatric surgery. The 30 patients were divided into two groups: Group A: 19 patients who had undergone monsplasty with abdominoplasty, and Group B: 11 patients who opted for standard abdominoplasty without monsplasty. Results: Every individual in group 1 was quite pleased with their surgical outcomes. At the 6-month follow-up, the surgical correction had appeared permanent, with no signs of residual or recurrent deformity. In Group A, all participants underwent monsplasty and were 100% satisfied. In contrast, none in Group B had monsplasty, and only 18.2% were satisfied. The difference in Satisfaction between the groups is statistically significant [p<0.001]. There was no residual or recurrent deformity at the 6-month follow-up. And the results of the surgery seemed to be long-lasting. Conclusion: The findings of this research provide evidence that modifications to the conventional treatment for pubic deformity following large weight reduction are safe, readily repeatable, provide a high degree of aesthetic and functional outcome, and have long lasting effects.
{"title":"Assessment of Outcomes of Abdominoplasty Combined with Monsplasty in Post Massive Weight Loss Patients","authors":"Mahmoud Mahmoud, Mohamed Abdel-Maksoud, Osama Almezaien","doi":"10.21608/ijma.2023.227291.1760","DOIUrl":"https://doi.org/10.21608/ijma.2023.227291.1760","url":null,"abstract":"Article information Background: One of the most common procedures for changing the shape of a person's body is abdominoplasty, which often includes monsplasty. It is one of the top five procedures in cosmetic surgery. Abdominoplasty and body lift operations may begin with a monsplasty. Here, we detail a novel method for treating pubic deformities triggered by massive weight reduction. Aim of the Work: The purpose of this research was to evaluate how happy our patients were with the results of their monsplasty and abdominoplasty procedures following significant weight loss. Our team also tried to develop a surgical care decision-making system. Patients and Methods: This prospective study involved 30 cases designed to assess the outcome of a combination of both abdominoplasty with monsplasty in patients with massive weight loss either dietary or post bariatric surgery. The 30 patients were divided into two groups: Group A: 19 patients who had undergone monsplasty with abdominoplasty, and Group B: 11 patients who opted for standard abdominoplasty without monsplasty. Results: Every individual in group 1 was quite pleased with their surgical outcomes. At the 6-month follow-up, the surgical correction had appeared permanent, with no signs of residual or recurrent deformity. In Group A, all participants underwent monsplasty and were 100% satisfied. In contrast, none in Group B had monsplasty, and only 18.2% were satisfied. The difference in Satisfaction between the groups is statistically significant [p<0.001]. There was no residual or recurrent deformity at the 6-month follow-up. And the results of the surgery seemed to be long-lasting. Conclusion: The findings of this research provide evidence that modifications to the conventional treatment for pubic deformity following large weight reduction are safe, readily repeatable, provide a high degree of aesthetic and functional outcome, and have long lasting effects.","PeriodicalId":53130,"journal":{"name":"International Journal of Medical Arts","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139331107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-01DOI: 10.21608/ijma.2023.248281.1865
Malek Talaat Abd Alfatah, Tawfik Nour –Eldeen, Adel Diab
Article information Background: The central venous pressure [CVP] remains the most frequently used variable to guide fluid resuscitation in shocked patients and is considered a direct measurement of the blood pressure in the right atrium and vena cava. The ultrasound-guided measurement of the inferior vena cava [IVC] and its changes with respiration has recently been utilized to calculate a patient's fluid status. The Aim of the work: This work aimed to compare ultrasound guided inferior vena cava dispensability index to central venous pressure in shocked patients and to assess the volume status in shocked patients after measurement of CVP and IVC dispensability index [IVC DI]. Patients and Methods: The study was conducted on 60 shocked patients, who were selected from the ICU, Al-Azhar University Hospitals. Results: At cutoff point 7.5 cmH 2 O, CVP has a sensitivity of 97% and specificity of 96.3% for prediction of hypovolemia. Also, at cutoff point 15.5, IVC-DI has sensitivity of 93.9% and specificity of 100% to predict hypovolemia. In addition, CVP at cutoff point 8.5 cmH 2 O has sensitivity of 50% and specificity of 55% for predicting fluid responsiveness. Also, at cutoff point 14.5 IVC DI has sensitivity of 100% and specificity of 91.9% for predicting fluid responsiveness. Conclusion: Ultrasound guided CVP and IVC DI were reliable markers in predicting fluid responsiveness and hypovolemia among shocked patients. IVC DI was superior than central CVP.
文章信息 背景：中心静脉压（CVP）仍是指导休克患者液体复苏最常用的变量，被认为是右心房和腔静脉血压的直接测量值。最近，在超声引导下测量下腔静脉（IVC）及其随呼吸的变化被用于计算患者的液体状态。工作目的：这项工作旨在比较休克患者在超声引导下的下腔静脉可支配指数和中心静脉压，并评估休克患者在测量中心静脉压和下腔静脉可支配指数[IVC DI]后的血容量状况。患者和方法：该研究选取了爱资哈尔大学医院重症监护室的 60 名休克患者。研究结果在截断点 7.5 cmH 2 O 时，CVP 预测低血容量的灵敏度为 97%，特异度为 96.3%。同样，在截断点 15.5 时，IVC-DI 预测血容量不足的灵敏度为 93.9%，特异度为 100%。此外，CVP 临界点为 8.5 cmH 2 O 时，预测输液反应性的灵敏度为 50%，特异度为 55%。同样，在 14.5 IVC DI 临界点时，预测输液反应性的敏感性为 100%，特异性为 91.9%。结论超声引导下的 CVP 和 IVC DI 是预测休克患者输液反应性和低血容量的可靠指标。IVC DI 优于中心 CVP。
{"title":"Inferior Vena Cava Dispensability Index versus Central Venous Pressure in Volume Status Assessment in Shocked Patients","authors":"Malek Talaat Abd Alfatah, Tawfik Nour –Eldeen, Adel Diab","doi":"10.21608/ijma.2023.248281.1865","DOIUrl":"https://doi.org/10.21608/ijma.2023.248281.1865","url":null,"abstract":"Article information Background: The central venous pressure [CVP] remains the most frequently used variable to guide fluid resuscitation in shocked patients and is considered a direct measurement of the blood pressure in the right atrium and vena cava. The ultrasound-guided measurement of the inferior vena cava [IVC] and its changes with respiration has recently been utilized to calculate a patient's fluid status. The Aim of the work: This work aimed to compare ultrasound guided inferior vena cava dispensability index to central venous pressure in shocked patients and to assess the volume status in shocked patients after measurement of CVP and IVC dispensability index [IVC DI]. Patients and Methods: The study was conducted on 60 shocked patients, who were selected from the ICU, Al-Azhar University Hospitals. Results: At cutoff point 7.5 cmH 2 O, CVP has a sensitivity of 97% and specificity of 96.3% for prediction of hypovolemia. Also, at cutoff point 15.5, IVC-DI has sensitivity of 93.9% and specificity of 100% to predict hypovolemia. In addition, CVP at cutoff point 8.5 cmH 2 O has sensitivity of 50% and specificity of 55% for predicting fluid responsiveness. Also, at cutoff point 14.5 IVC DI has sensitivity of 100% and specificity of 91.9% for predicting fluid responsiveness. Conclusion: Ultrasound guided CVP and IVC DI were reliable markers in predicting fluid responsiveness and hypovolemia among shocked patients. IVC DI was superior than central CVP.","PeriodicalId":53130,"journal":{"name":"International Journal of Medical Arts","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139328951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-01DOI: 10.21608/ijma.2023.227617.1761
Shasi V.
ABSTRACT
摘要
{"title":"A Retrospective Audit of Fresh Frozen Plasma Usage in a Tertiary Care Hospital in South India","authors":"Shasi V.","doi":"10.21608/ijma.2023.227617.1761","DOIUrl":"https://doi.org/10.21608/ijma.2023.227617.1761","url":null,"abstract":"ABSTRACT","PeriodicalId":53130,"journal":{"name":"International Journal of Medical Arts","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139331518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-01DOI: 10.21608/ijma.2023.234787.1803
Muhamed Abdelmoaty, Elsayed Ibrahim, Adel Elboghdady
Article information Background: Pre-eclampsia causes high maternal and newborn mortality. Hypertensive diseases during pregnancy kill Egyptian mothers and 10% of pregnant women worldwide. Preterm pre-eclampsia, a severe variant, increases mother and infant risks. Delivery is the only therapy, which might cause difficulties in premature situations. Metformin, a blood glucose medicine, may cure pre-eclampsia, according to preclinical research. However, safe and effective preterm pre-eclampsia medications are required. Aim of the Work: The study aims to investigate whether or not metformin with extended release can lengthen pregnancy in women who have been diagnosed with premature pre-eclampsia. Patients and Methods: A double-blind, placebo-controlled clinical trial was done involving cases diagnosed with preterm pre-eclampsia between 26+0 and 31+6 weeks of gestation. The cases were given either extended release metformin or a placebo according to a random assignment. Maternal and fetal surveillance was conducted, and various outcome measures were assessed, including gestation prolongation, fetal, composite maternal, and levels of anti-angiogenic biomarkers related to pre-eclampsia, and neonatal outcomes. Results: The study found that there was no significant variance in the characteristics of women among the two groups. Gestation was significantly prolonged in the metformin group contrasted with the placebo group. The incidence of HELLP syndrome was significantly greater in the placebo group. Other outcomes did not show significant differences among the groups, except for a higher number of cases reaching 34 weeks' gestation in the metformin group. Conclusion: The findings suggest that preterm preeclamptic women may benefit from using extended-release metformin to prolong gestation. However, more study is required to fully evaluate its safety and effectiveness as a treatment option.
{"title":"Can Metformin Be Used to Prolong Gestation in Egyptian Women with Early Preterm Pre-Eclampsia? A Randomized Clinical Trial","authors":"Muhamed Abdelmoaty, Elsayed Ibrahim, Adel Elboghdady","doi":"10.21608/ijma.2023.234787.1803","DOIUrl":"https://doi.org/10.21608/ijma.2023.234787.1803","url":null,"abstract":"Article information Background: Pre-eclampsia causes high maternal and newborn mortality. Hypertensive diseases during pregnancy kill Egyptian mothers and 10% of pregnant women worldwide. Preterm pre-eclampsia, a severe variant, increases mother and infant risks. Delivery is the only therapy, which might cause difficulties in premature situations. Metformin, a blood glucose medicine, may cure pre-eclampsia, according to preclinical research. However, safe and effective preterm pre-eclampsia medications are required. Aim of the Work: The study aims to investigate whether or not metformin with extended release can lengthen pregnancy in women who have been diagnosed with premature pre-eclampsia. Patients and Methods: A double-blind, placebo-controlled clinical trial was done involving cases diagnosed with preterm pre-eclampsia between 26+0 and 31+6 weeks of gestation. The cases were given either extended release metformin or a placebo according to a random assignment. Maternal and fetal surveillance was conducted, and various outcome measures were assessed, including gestation prolongation, fetal, composite maternal, and levels of anti-angiogenic biomarkers related to pre-eclampsia, and neonatal outcomes. Results: The study found that there was no significant variance in the characteristics of women among the two groups. Gestation was significantly prolonged in the metformin group contrasted with the placebo group. The incidence of HELLP syndrome was significantly greater in the placebo group. Other outcomes did not show significant differences among the groups, except for a higher number of cases reaching 34 weeks' gestation in the metformin group. Conclusion: The findings suggest that preterm preeclamptic women may benefit from using extended-release metformin to prolong gestation. However, more study is required to fully evaluate its safety and effectiveness as a treatment option.","PeriodicalId":53130,"journal":{"name":"International Journal of Medical Arts","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139326644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-01DOI: 10.21608/ijma.2023.209653.1681
Mohamed NorEldien, M. Gebreel, A. Marai
Article information Background: Myomectomy is a common surgical intervention for the removal of uterine fibroids. Excessive blood loss during the procedure remains a concern. However, there is currently no agreement on the optimal method for minimizing blood loss during myomectomy procedures. Aim of the Work: This comparative study aimed to assess the efficacy of two approaches, namely preoperative misoprostol administration and intraoperative cervical hemostatic uterine artery ligation, in reducing intraoperative blood loss. Patients and Methods: A prospective randomized controlled trial was conducted, including a total of 80 patients undergoing myomectomy for symptomatic uterine fibroids. These patients were divided into two groups: Group A [40 patients] received preoperative misoprostol and Group B [40 patients] underwent intraoperative cervical hemostatic uterine artery ligation. The primary outcome measure was the difference in blood loss between the two groups. Secondary outcomes included operation time, postoperative hemoglobin levels and transfusion rates. Results: The findings revealed that the amount blood loss was significantly less in Uterine Artery Ligation group. The mean blood loss in Group A was 440.0±78.1 ml, while in Group B, it was 375.0±96.3 ml [p 0.006]. Furthermore, Group B demonstrated a lower transfusion rate and higher postoperative hemoglobin levels compared to Group A. Conclusion: Intraoperative cervical hemostatic uterine artery ligation was found to be more effective than preoperative misoprostol administration in reducing blood loss during myomectomy procedures. This technique shows promise in improving surgical outcomes, minimizing blood loss, and potentially reducing the need for blood transfusion, but further research and long-term follow-up studies are needed for validation and to determine its clinical significance.
{"title":"Comparative Study of Preoperative Misoprostol versus Intraoperative Hemostatic Uterine Artery Ligation in Reducing Blood Loss in Cases of Myomectomy","authors":"Mohamed NorEldien, M. Gebreel, A. Marai","doi":"10.21608/ijma.2023.209653.1681","DOIUrl":"https://doi.org/10.21608/ijma.2023.209653.1681","url":null,"abstract":"Article information Background: Myomectomy is a common surgical intervention for the removal of uterine fibroids. Excessive blood loss during the procedure remains a concern. However, there is currently no agreement on the optimal method for minimizing blood loss during myomectomy procedures. Aim of the Work: This comparative study aimed to assess the efficacy of two approaches, namely preoperative misoprostol administration and intraoperative cervical hemostatic uterine artery ligation, in reducing intraoperative blood loss. Patients and Methods: A prospective randomized controlled trial was conducted, including a total of 80 patients undergoing myomectomy for symptomatic uterine fibroids. These patients were divided into two groups: Group A [40 patients] received preoperative misoprostol and Group B [40 patients] underwent intraoperative cervical hemostatic uterine artery ligation. The primary outcome measure was the difference in blood loss between the two groups. Secondary outcomes included operation time, postoperative hemoglobin levels and transfusion rates. Results: The findings revealed that the amount blood loss was significantly less in Uterine Artery Ligation group. The mean blood loss in Group A was 440.0±78.1 ml, while in Group B, it was 375.0±96.3 ml [p 0.006]. Furthermore, Group B demonstrated a lower transfusion rate and higher postoperative hemoglobin levels compared to Group A. Conclusion: Intraoperative cervical hemostatic uterine artery ligation was found to be more effective than preoperative misoprostol administration in reducing blood loss during myomectomy procedures. This technique shows promise in improving surgical outcomes, minimizing blood loss, and potentially reducing the need for blood transfusion, but further research and long-term follow-up studies are needed for validation and to determine its clinical significance.","PeriodicalId":53130,"journal":{"name":"International Journal of Medical Arts","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139326856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-01DOI: 10.21608/ijma.2023.230752.1786
Esam Eshaweirf, Abdesalam Sougei
Article information Background: The practice of immediately placing dental implants has grown widespread in the field of oral implantology, and there is ongoing discussion on the optimal surgical technique, namely whether to use a flap or flapless approach. The objective of this study was to evaluate and compare the results of these two procedures in relation to gum health, bleeding during probing, soft tissue thickness, implant durability, bone loss, and bone density. The Aim of the work: We aim to examine and contrast the results of instantaneous implant implantation operations using two distinct surgical methods: flap surgery and flapless surgery. Patients and Methods: A total of forty patients who were scheduled for implant surgery at the Maxillofacial Department Surgery were assigned to two distinct groups: Group I, which underwent flapless surgery, and Group II, which underwent flap surgery. The study evaluated various parameters including the gum health index, bleeding during probing, soft tissue thickness around and on top of the implants, implant stability, bone loss, and bone density. These assessments were conducted at the start of the trial and again after a 6-month follow-up. Results: There were no notable disparities in the average gum health index and bleeding during probing between the two groups at the start and after 6 months. There were no notable variations in the thickness of the soft tissue surrounding the teeth on the sides. Nevertheless, the thickness of the soft tissue covering the teeth was notably reduced in the group that underwent flap surgery. The implant stability was similar in both groups. Conclusion: Flapless surgery exhibited similar results to flap surgery in terms of gum health, bleeding during probing, soft tissue thickness, and implant stability. Nevertheless, it shown benefits in preserving the thickness of the soft tissue above the teeth and preventing excessive bone loss and decreased bone
{"title":"Immediate Implant Placement with Flap or Flapless Surgery","authors":"Esam Eshaweirf, Abdesalam Sougei","doi":"10.21608/ijma.2023.230752.1786","DOIUrl":"https://doi.org/10.21608/ijma.2023.230752.1786","url":null,"abstract":"Article information Background: The practice of immediately placing dental implants has grown widespread in the field of oral implantology, and there is ongoing discussion on the optimal surgical technique, namely whether to use a flap or flapless approach. The objective of this study was to evaluate and compare the results of these two procedures in relation to gum health, bleeding during probing, soft tissue thickness, implant durability, bone loss, and bone density. The Aim of the work: We aim to examine and contrast the results of instantaneous implant implantation operations using two distinct surgical methods: flap surgery and flapless surgery. Patients and Methods: A total of forty patients who were scheduled for implant surgery at the Maxillofacial Department Surgery were assigned to two distinct groups: Group I, which underwent flapless surgery, and Group II, which underwent flap surgery. The study evaluated various parameters including the gum health index, bleeding during probing, soft tissue thickness around and on top of the implants, implant stability, bone loss, and bone density. These assessments were conducted at the start of the trial and again after a 6-month follow-up. Results: There were no notable disparities in the average gum health index and bleeding during probing between the two groups at the start and after 6 months. There were no notable variations in the thickness of the soft tissue surrounding the teeth on the sides. Nevertheless, the thickness of the soft tissue covering the teeth was notably reduced in the group that underwent flap surgery. The implant stability was similar in both groups. Conclusion: Flapless surgery exhibited similar results to flap surgery in terms of gum health, bleeding during probing, soft tissue thickness, and implant stability. Nevertheless, it shown benefits in preserving the thickness of the soft tissue above the teeth and preventing excessive bone loss and decreased bone","PeriodicalId":53130,"journal":{"name":"International Journal of Medical Arts","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139329869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-01DOI: 10.21608/ijma.2023.231731.1793
Sara Yossif, Hazem Abdel-Aleem, Khalid Tawfeek
Article information Background: Onychomycosis affecting 5.5% of the population worldwide which may be treated by medical antifungal therapy or laser therapy which is attractive to avoid side effects, prevent developing of microbial resistance and safe with no mutagenic or cytotoxic effect. Aim of the Work: To evaluate the efficacy and safety of diode 577-nm laser in the treatment of onychomycosis. Patients and Methods: This study involved 30 onychomycosis patients with 87 affected nails, everyone had two affected sites [finger nails/toe nails] then randomly allocated into two groups: group [A] in which one site was treated by diode laser [577-nm] plus Tioconazole 28% [Fungibacid 28% nail solution] nail solution while in group [B] the other site in the same patient was treated by Tioconazole 28% nail solution only. We assessed the improvement by Onychomycosis Severity Index [OSI], culture and patient satisfaction. Results: The OSI severity in Diode 577-nm + Tioconazole group decreased from 36.7% before treatment to 20% after 3 months an continue to decrease after 6 months to 3.3%. However, in Tioconazole only group, the severity still the same as before treatment 36.7% after 3 months while after 6 months decreased to 20%. There was a significant difference between patients with severe OSI score while no significant difference between patients with mild and moderate OSI score among both groups at the end of follow up. There were 2 [6.7%] patients after 3 months and 18 [60%] patients after 6 months have complete resolution in Diode 577-nm + Tioconazole group while in Tioconazole only group, no one has complete resolution after 3 months but after 6 months there were 11 [36.7%] patients have complete resolution with significant difference between both groups at 3 and 6 months [p < 0.001 & 0.046]. Conclusion: The 577-nm diode yellow laser is an effective and safe option for the treatment of onychomycosis.
{"title":"Diode 577-nm Laser Plus Tioconazole 28% Nail Solution versus Topical Tioconazole 28% Nail Solution Alone in Treatment of Onychomycosis","authors":"Sara Yossif, Hazem Abdel-Aleem, Khalid Tawfeek","doi":"10.21608/ijma.2023.231731.1793","DOIUrl":"https://doi.org/10.21608/ijma.2023.231731.1793","url":null,"abstract":"Article information Background: Onychomycosis affecting 5.5% of the population worldwide which may be treated by medical antifungal therapy or laser therapy which is attractive to avoid side effects, prevent developing of microbial resistance and safe with no mutagenic or cytotoxic effect. Aim of the Work: To evaluate the efficacy and safety of diode 577-nm laser in the treatment of onychomycosis. Patients and Methods: This study involved 30 onychomycosis patients with 87 affected nails, everyone had two affected sites [finger nails/toe nails] then randomly allocated into two groups: group [A] in which one site was treated by diode laser [577-nm] plus Tioconazole 28% [Fungibacid 28% nail solution] nail solution while in group [B] the other site in the same patient was treated by Tioconazole 28% nail solution only. We assessed the improvement by Onychomycosis Severity Index [OSI], culture and patient satisfaction. Results: The OSI severity in Diode 577-nm + Tioconazole group decreased from 36.7% before treatment to 20% after 3 months an continue to decrease after 6 months to 3.3%. However, in Tioconazole only group, the severity still the same as before treatment 36.7% after 3 months while after 6 months decreased to 20%. There was a significant difference between patients with severe OSI score while no significant difference between patients with mild and moderate OSI score among both groups at the end of follow up. There were 2 [6.7%] patients after 3 months and 18 [60%] patients after 6 months have complete resolution in Diode 577-nm + Tioconazole group while in Tioconazole only group, no one has complete resolution after 3 months but after 6 months there were 11 [36.7%] patients have complete resolution with significant difference between both groups at 3 and 6 months [p < 0.001 & 0.046]. Conclusion: The 577-nm diode yellow laser is an effective and safe option for the treatment of onychomycosis.","PeriodicalId":53130,"journal":{"name":"International Journal of Medical Arts","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139325591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-01DOI: 10.21608/ijma.2023.242815.1840
Asmaa Abd-Elnaby, Jihan Mohamed, M. Aly
Article information Objective: With the help of optical coherence tomography angiography, this study sought to determine if the retinal capillary plexus and choriocapillaris in diabetic macular edema patients' eyes had changed after Ranibizumab is administered intravitreally once. Patients and Methods: A prospective, interventional, randomized clinical trial with 20 diabetic macular edema patients' eyes were chosen from outpatient clinic Ophthalmology department of Al-Azhar university hospital, Cairo, Egypt during period from 2022 to 2023. Prior to intravitreal ranibizumab treatment and one month after, the visual acuity of each patient was assessed. Optical Coherence Tomography Angiography was performed at baseline preoperatively and 1 month postoperatively for assessing superficial capillary plexus, deep capillary plexus, vascular density, Foveal avascular zone, and choriocapillaris vessels density. Results: The BCVA showed a considerable improvement [p <0.001] and significant reduction in the CFT [p value < 0.001]. Also, choriocapillaris showed a significant improvement [p value < 0.001]. On the other hand, there were in significant changes in the superficial capillary plexus, deep capillary plexus, vascular density, and Foveal avascular zone before and after treatment. Conclusion: Intravitreal ranibizumab effectively decreased
{"title":"Assessment of Macular Microvascular Changes after Intravitreal Ranibizumab Injection in Diabetic Macular Edema","authors":"Asmaa Abd-Elnaby, Jihan Mohamed, M. Aly","doi":"10.21608/ijma.2023.242815.1840","DOIUrl":"https://doi.org/10.21608/ijma.2023.242815.1840","url":null,"abstract":"Article information Objective: With the help of optical coherence tomography angiography, this study sought to determine if the retinal capillary plexus and choriocapillaris in diabetic macular edema patients' eyes had changed after Ranibizumab is administered intravitreally once. Patients and Methods: A prospective, interventional, randomized clinical trial with 20 diabetic macular edema patients' eyes were chosen from outpatient clinic Ophthalmology department of Al-Azhar university hospital, Cairo, Egypt during period from 2022 to 2023. Prior to intravitreal ranibizumab treatment and one month after, the visual acuity of each patient was assessed. Optical Coherence Tomography Angiography was performed at baseline preoperatively and 1 month postoperatively for assessing superficial capillary plexus, deep capillary plexus, vascular density, Foveal avascular zone, and choriocapillaris vessels density. Results: The BCVA showed a considerable improvement [p <0.001] and significant reduction in the CFT [p value < 0.001]. Also, choriocapillaris showed a significant improvement [p value < 0.001]. On the other hand, there were in significant changes in the superficial capillary plexus, deep capillary plexus, vascular density, and Foveal avascular zone before and after treatment. Conclusion: Intravitreal ranibizumab effectively decreased","PeriodicalId":53130,"journal":{"name":"International Journal of Medical Arts","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139326174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Article information Background: Articaine has been used as a local anesthetic for dental procedures, but studies about articaine used as a local anesthetic for regional block after thoracic surgeries are limited. Aim of the Study: Our study compares the postoperative analgesic efficacy of articaine 2% and bupivacaine 0.25% through erector spinae block for after thoracic surgeries. Patients and Methods: All patients were divided into two groups. Group I [20 patients] [erector spinae block with bupivacine 0.25%] was performed before extubation with an injection of 30 ml of 0.25% bupivacine. Group II [20 patients] [erector spinae block with articaine 2%] was performed before extubation with an injection of 30 ml of articaine 2%. Results: As regard the visual analogue scale at 8 h and 12 h, postoperatively, there was significant variance among the 2 groups [p value=0.045, p value=0.002]. Also, with regard to first-rescue analgesia and the total dose of morphine, there was significant variance among the 2 groups [p value=0.006, p value=0.02]. Conclusion: Articaine is a reliable local anesthetic agent when compared to bupivacaine for regional
{"title":"A Comparative Study of The Analgesic Effect of Articaine 2% for Management of Postoperative Pain after Thoracotomy Using Ultrasound-Guided Erector Spinae Plane Block","authors":"Elsayed Abdelazeem, Neveen Kohaf, Mohamed Emeliegy, Mohamed Elmeliegy","doi":"10.21608/ijma.2023.239251.1823","DOIUrl":"https://doi.org/10.21608/ijma.2023.239251.1823","url":null,"abstract":"Article information Background: Articaine has been used as a local anesthetic for dental procedures, but studies about articaine used as a local anesthetic for regional block after thoracic surgeries are limited. Aim of the Study: Our study compares the postoperative analgesic efficacy of articaine 2% and bupivacaine 0.25% through erector spinae block for after thoracic surgeries. Patients and Methods: All patients were divided into two groups. Group I [20 patients] [erector spinae block with bupivacine 0.25%] was performed before extubation with an injection of 30 ml of 0.25% bupivacine. Group II [20 patients] [erector spinae block with articaine 2%] was performed before extubation with an injection of 30 ml of articaine 2%. Results: As regard the visual analogue scale at 8 h and 12 h, postoperatively, there was significant variance among the 2 groups [p value=0.045, p value=0.002]. Also, with regard to first-rescue analgesia and the total dose of morphine, there was significant variance among the 2 groups [p value=0.006, p value=0.02]. Conclusion: Articaine is a reliable local anesthetic agent when compared to bupivacaine for regional","PeriodicalId":53130,"journal":{"name":"International Journal of Medical Arts","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139331397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-01DOI: 10.21608/ijma.2023.246932.1858
Gomaa Gomaa, Mostafa Aboelenin, Yousry Abdelsalam
Article information Background: When a patient is admitted to the intensive care unit [ICU], organ dysfunction is thought to be the primary cause of death and complications. Since its development in the 1990s, the sequential organ failure assessment [SOFA] score has been used in critical care to assess and forecast acute morbidities and related patient outcomes. The Aim of the work: For assessment SOFA score ability as a diagnostic indicator in predicting traumatic patients’ outcome in the ICU. Patients and Methods: This was a prospective cross-sectional study conducted on all trauma patients who admitted to ICU at Damietta Al-Azhar University Hospital. After approval of ethical committee 70 patients of them ranged from 18 to 69 years were selected. Results: Regarding the cause of admission in the studied population, 24% was abdominal trauma followed by ICH in 20%, multiple fracture in 17.1%, subdural hematoma and pneumothorax in 14.29% for each then Brain contusion in 10% of included patients. The duration of hospital stay ranged between 4-20 days with mean duration of 9.600 ± 4.095 days. SOFA score has sensitivity of 91.7% and specificity of 100% for predicting mortality, at cutoff point 5.5. There was statistical significance positive correlation between SOFA score and the duration of hospital stay. Conclusion: There is statistically significant positive correlation between SOFA score and the duration of hospital stay so It is suggested that SOFA score be used as a suitable tool to predict patients’ outcomes.
{"title":"Impact of SOFA Score on The Outcomes of Traumatic Patient in Intensive Care Unit","authors":"Gomaa Gomaa, Mostafa Aboelenin, Yousry Abdelsalam","doi":"10.21608/ijma.2023.246932.1858","DOIUrl":"https://doi.org/10.21608/ijma.2023.246932.1858","url":null,"abstract":"Article information Background: When a patient is admitted to the intensive care unit [ICU], organ dysfunction is thought to be the primary cause of death and complications. Since its development in the 1990s, the sequential organ failure assessment [SOFA] score has been used in critical care to assess and forecast acute morbidities and related patient outcomes. The Aim of the work: For assessment SOFA score ability as a diagnostic indicator in predicting traumatic patients’ outcome in the ICU. Patients and Methods: This was a prospective cross-sectional study conducted on all trauma patients who admitted to ICU at Damietta Al-Azhar University Hospital. After approval of ethical committee 70 patients of them ranged from 18 to 69 years were selected. Results: Regarding the cause of admission in the studied population, 24% was abdominal trauma followed by ICH in 20%, multiple fracture in 17.1%, subdural hematoma and pneumothorax in 14.29% for each then Brain contusion in 10% of included patients. The duration of hospital stay ranged between 4-20 days with mean duration of 9.600 ± 4.095 days. SOFA score has sensitivity of 91.7% and specificity of 100% for predicting mortality, at cutoff point 5.5. There was statistical significance positive correlation between SOFA score and the duration of hospital stay. Conclusion: There is statistically significant positive correlation between SOFA score and the duration of hospital stay so It is suggested that SOFA score be used as a suitable tool to predict patients’ outcomes.","PeriodicalId":53130,"journal":{"name":"International Journal of Medical Arts","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139325061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：